Literature DB >> 12670914

A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2).

You-Wei Zhang1, Keiko Nakayama, Kei-Ichi Nakayama, Ikuo Morita.   

Abstract

Accumulated evidence suggests that connexin43 (Cx43) serves as a tumor-suppressing gene. We have previously shownA. B. that Cx43 suppressed the G(1)-S phase cell cycle transition via increasing the level of p27 (Zhang, Y. W., et al., Oncogene, 20: 4138-4149, 2001). Here we report that Cx43 inhibited expression of Skp2, the human F-box protein that regulates p27 ubiquitination. This reduction was attributed to an increased degradation of Skp2. The Cx43 antisense oligonucleotide blocked this inhibitory effect of Cx43 on Skp2 expression and led to p27 down-regulation. In contrast, the antisense oligonucleotide of Skp2 induced a further increase in the level of p27. However, ectopic expression of Skp2 reversed the Cx43-induced Skp2 reduction, p27 accumulation, and cell proliferation inhibition. Cx43 increased p27 expression only in the SKP2 +/+ mouse embryo fibroblasts (MEFs), but not in the SKP2 -/- MEFs, indicating that Skp2 plays a critical role in the Cx43-induced p27 up-regulation. We also show that both Skp2 and p27 are required for Cx43 to inhibit cell proliferation, in that Cx43 hardly inhibited cell proliferation of the SKP2 -/- and p27 -/- MEFs, whereas it clearly did both in the SKP2 +/- and in the p27 +/- MEFs. Our findings suggest a new route for Cx43 to inhibit tumor growth by linking it with the key cell cycle regulators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670914

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Regulation of gap junctions by tyrosine protein kinases.

Authors:  Bonnie J Warn-Cramer; Alan F Lau
Journal:  Biochim Biophys Acta       Date:  2004-03-23

Review 2.  Gap junction- and hemichannel-independent actions of connexins.

Authors:  Jean X Jiang; Sumin Gu
Journal:  Biochim Biophys Acta       Date:  2004-10-22

Review 3.  Biological role of connexin intercellular channels and hemichannels.

Authors:  Rekha Kar; Nidhi Batra; Manuel A Riquelme; Jean X Jiang
Journal:  Arch Biochem Biophys       Date:  2012-03-17       Impact factor: 4.013

Review 4.  The role of gap junction channels during physiologic and pathologic conditions of the human central nervous system.

Authors:  Eliseo A Eugenin; Daniel Basilio; Juan C Sáez; Juan A Orellana; Cedric S Raine; Feliksas Bukauskas; Michael V L Bennett; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-23       Impact factor: 4.147

Review 5.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

6.  Amino acid residue Val362 plays a critical role in maintaining the structure of C terminus of connexin 50 and in lens epithelial-fiber differentiation.

Authors:  Qian Shi; Eric A Banks; X Sean Yu; Sumin Gu; Janelle Lauer; Gregg B Fields; Jean X Jiang
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

7.  Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27Kip1-deficient mice.

Authors:  Timothy J King; Paul D Lampe
Journal:  Cell Commun Adhes       Date:  2005 Jul-Dec

8.  Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis in vivo.

Authors:  Mark J Ableser; Silvia Penuela; Jack Lee; Qing Shao; Dale W Laird
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

9.  Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts.

Authors:  Yan Zhang; Evelyn M Kanter; James G Laing; Colette Aprhys; David C Johns; Elissavet Kardami; Kathryn A Yamada
Journal:  Cell Commun Adhes       Date:  2008-09

10.  Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.

Authors:  Rosy Joshi-Mukherjee; Wanda Coombs; Hassan Musa; Eva Oxford; Steven Taffet; Mario Delmar
Journal:  Heart Rhythm       Date:  2008-09-06       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.